AIDS Transmission

67% Drop in U.S. Perinatal AIDS Linked to Maternal AZT

Published in Medical Letter on the CDC and FDA, August 23rd, 1999

AIDS cases among infants and children in the U.S. have dropped by two-thirds, reports the U.S. Centers for Disease Control and Prevention (CDC).

This dramatic decrease is linked to the use of zidovudine (AZT) by HIV infected mothers. AZT taken during pregnancy greatly reduces the chance that an HIV infected woman will transmit the virus to her child. In 1994 the U.S. Public Health Service (PHS) recommended that all HIV positive pregnant women receive AZT.

CDC researcher Mary Lou Lindegren and colleagues analyzed U.S. AIDS surveillance data, including information from HIV reporting states, collected through June 1998.

"According...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (1999-08-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry